Tenax Therapeutics, Inc. announced it raised $5.17 Million in an initial filing from an offering of $5.17 Million
Tenax Therapeutics, Inc. announced it raised $5.17 Million in an initial filing from an offering of $5.17 Million
07/22/20, 9:00 PM
Location
chapell hillMoney raised
$5.17 million
Industry
healthcare
Company Info
Location
101 glen lennox drive
chapell hill, north carolina, united states
Additional Info
Tenax Therapeutics is a Phase 3, development-stage pharmaceutical company focused on developing and commercializing therapeutics that address cardiovascular and pulmonary diseases with high unmet medical need, with a current focus on pulmonary hypertension.